Ustekinumab as induction and maintenance therapy for Crohn’s disease BG Feagan, WJ Sandborn, C Gasink, D Jacobstein, Y Lang, JR Friedman, ... New England journal of medicine 375 (20), 1946-1960, 2016 | 1737 | 2016 |
Prednisolone or pentoxifylline for alcoholic hepatitis MR Thursz, P Richardson, M Allison, A Austin, M Bowers, CP Day, ... New England Journal of Medicine 372 (17), 1619-1628, 2015 | 803 | 2015 |
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial JG Williams, MF Alam, L Alrubaiy, I Arnott, C Clement, D Cohen, ... The lancet Gastroenterology & hepatology 1 (1), 15-24, 2016 | 229 | 2016 |
Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis TJ Creed, MR Norman, CSJ Probert, RF Harvey, IS Shaw, J Smithson, ... Alimentary pharmacology & therapeutics 18 (1), 65-75, 2003 | 180 | 2003 |
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? CAM McNulty, G Lasseter, I Shaw, T Nichols, S D'Arcy, AJ Lawson, ... Alimentary pharmacology & therapeutics 35 (10), 1221-1230, 2012 | 92 | 2012 |
Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK R Kapasi, J Glatter, CA Lamb, AG Acheson, C Andrews, ID Arnott, ... Frontline Gastroenterology 11 (3), 178-187, 2020 | 80 | 2020 |
Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission NA Syed, SD Hearing, IS Shaw, CSJ Probert, TN Brooklyn, EO Caul, ... European journal of gastroenterology & hepatology 15 (8), 901-906, 2003 | 60 | 2003 |
Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: results from InspirADA S Travis, BG Feagan, L Peyrin-Biroulet, R Panaccione, S Danese, A Lazar, ... Journal of Crohn's and Colitis 11 (11), 1317-1325, 2017 | 46 | 2017 |
Focal active colitis: a prospective study of clinicopathological correlations in 90 patients S Shetty, SM Anjarwalla, J Gupta, CJW Foy, IS Shaw, RM Valori, ... Histopathology 59 (5), 850-856, 2011 | 37 | 2011 |
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its … CSJ Probert, S Sebastian, DR Gaya, PJ Hamlin, G Gillespie, A Rose, ... BMJ Open Gastroenterology 5 (1), e000212, 2018 | 28 | 2018 |
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational study CJ Vaizey, PR Gibson, CM Black, RJ Nicholls, AR Weston, DR Gaya, ... Frontline Gastroenterology 5 (3), 183-189, 2014 | 28* | 2014 |
Insights into endoscopy training: a qualitative study of learning experience AI Thuraisingam, J MacDonald, IS Shaw Medical teacher 28 (5), 453-459, 2006 | 27 | 2006 |
Is mesalazine really safe for use in breastfeeding mothers? DA Silverman, J Ford, I Shaw, CSJ Probert Gut 54 (1), 170-171, 2005 | 27 | 2005 |
Is your patient taking the medicine? A simple assay to measure compliance with 5‐aminosalicylic acid‐containing compounds IS Shaw, BA Jobson, D Silverman, J Ford, SD Hearing, D Ball, E Johnson, ... Alimentary pharmacology & therapeutics 16 (12), 2053-2059, 2002 | 19 | 2002 |
I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ... Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023 | 18 | 2023 |
Limited impact on endoscopy demand from a primary care based ‘test and treat’dyspepsia management strategy: the results of a randomised controlled trial IS Shaw, RM Valori, A Charlett, CAM McNulty British journal of general practice 56 (526), 369-374, 2006 | 13* | 2006 |
Recognising depression in primary care I Shaw, H Middleton Journal of Primary Care Mental Health 5 (2), 24-27, 2001 | 13 | 2001 |
Benefits of structured pediatric to adult transition in inflammatory bowel disease: the TRANSIT observational study S McCartney, JO Lindsay, RK Russell, DR Gaya, I Shaw, CD Murray, ... Journal of Pediatric Gastroenterology and Nutrition 74 (2), 208-214, 2022 | 12 | 2022 |
Infliximab versus ciclosporin for steroid‐resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open‐label, pragmatic randomised trial. Lancet Gastroenterol … JG Williams, MF Alam, L Alrubaiy, I Arnott, C Clement, D Cohen, ... Published by S. Karger AG, Basel www. karger. com/crg Philippou et al …, 2021 | 10 | 2021 |
Comfort scores in colonoscopy performance VE Ekkelenkamp, I Shaw, R Valori, P Dunckley Gut 60 (Suppl 1), A44-A45, 2011 | 9 | 2011 |